We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
+9.27%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+879.75%
AUM
$49B
AUM Growth
+$3.11B
(+6.8%)
Cap. Flow
+$228M
Cap. Flow
% of AUM
0.47%
Top 10 Holdings %
Top 10 Hldgs %
21.37%
Holding
1,104
New
303
Increased
294
Reduced
324
Closed
153
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
+$282M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$205M |
| 3 |
ConocoPhillips
COP
|
+$203M |
| 4 |
Fortive
FTV
|
+$200M |
| 5 |
Merck
MRK
|
+$178M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Royalty Pharma
RPRX
|
+$665M |
| 2 |
ExxonMobil
XOM
|
+$332M |
| 3 |
Burlington
BURL
|
+$242M |
| 4 |
National Vision
EYE
|
+$186M |
| 5 |
CXO
CONCHO RESOURCES INC.
CXO
|
+$175M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.67% |
| 2 | Healthcare | 17.99% |
| 3 | Financials | 14.03% |
| 4 | Consumer Discretionary | 11.97% |
| 5 | Communication Services | 8.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
551
Velocity Financial
VEL
$719M
| $15.1M | 0.03% |
1,700,000
-31,358
| -2% | -$240K |
|
552
Abeona Therapeutics
ABEO
$393M
| $15.1M | 0.03% |
320,291
-11,229
| -3% | -$619K |
|
553
Pool Corp
POOL
$7.31B
| $15.1M | 0.03% |
43,600
-800
| -2% | -$279K |
|
|
NXU.U
554
DELISTED
Novus Capital Corporation II Units, each consisting of one share of Class A common stock and one thi
NXU.U
| $15M | 0.03% |
+1,500,000
| New | +$15.7M |
|
555
Uber
UBER
$144B
| $15M | 0.03% |
275,000
+100,000
| +57% | +$5.58M |
|
|
NVSAU
556
DELISTED
New Vista Acquisition Corp Unit
NVSAU
| $15M | 0.03% |
+1,500,350
| New | +$15.5M |
|
|
APGB.U
557
DELISTED
Apollo Strategic Growth Capital II Units, each consisting of one Class A ordinary share, and one-fifth of one warrant
APGB.U
| $15M | 0.03% |
+1,500,000
| New | +$15.4M |
|
|
GSEVU
558
DELISTED
Gores Holdings VII, Inc. Units
GSEVU
| $14.9M | 0.03% |
+1,500,000
| New | +$15.3M |
|
559
Textron
TXT
$15.1B
| $14.9M | 0.03% |
266,161
+66,400
| +33% | +$3.36M |
|
|
LCAAU
560
DELISTED
L Catterton Asia Acquisition Corp Units
LCAAU
| $14.9M | 0.03% |
+1,500,000
| New | +$15M |
|
561
Whirlpool
WHR
$2.8B
| $14.8M | 0.03% |
67,092
-1,300
| -2% | -$258K |
|
|
CTXS
562
DELISTED
Citrix Systems Inc
CTXS
| $14.7M | 0.03% |
104,900
+2,400
| +2% | +$322K |
|
563
Idacorp
IDA
$8.15B
| $14.5M | 0.03% |
+145,000
| New | +$13.3M |
|
564
C.H. Robinson
CHRW
$17.1B
| $14.4M | 0.03% |
151,400
+5,400
| +4% | +$504K |
|
565
Wynn Resorts
WYNN
$10.5B
| $14.4M | 0.03% |
115,000
+7,200
| +7% | +$868K |
|
566
Seagate
STX
$193B
| $14.3M | 0.03% |
186,500
+5,800
| +3% | +$404K |
|
|
AGCB
567
DELISTED
Altimeter Growth Corp 2
AGCB
| $14.3M | 0.03% |
+1,375,000
| New | +$16.4M |
|
|
WRK
568
DELISTED
WestRock Company
WRK
| $14.3M | 0.03% |
273,989
-5,500
| -2% | -$257K |
|
569
Cullinan Oncology
CGEM
$1.16B
| $14.2M | 0.03% |
+341,731
| New | +$13.9M |
|
570
Lyft
LYFT
$6.19B
| $14.2M | 0.03% |
225,000
-320,000
| -59% | -$17.9M |
|
571
Karyopharm Therapeutics
KPTI
$44.2M
| $14.2M | 0.03% |
89,987
-74,346
| -45% | -$15.7M |
|
572
Par Pacific Holdings
PARR
$3.45B
| $14.1M | 0.03% |
+1,000,000
| New | +$15.5M |
|
573
Lincoln National
LNC
$8.93B
| $14.1M | 0.03% |
225,661
+26,200
| +13% | +$1.45M |
|
574
Bristow Group
VTOL
$1.33B
| $14M | 0.03% |
541,818
-8,182
| -1% | -$223K |
|
575
PJT Partners
PJT
$4.42B
| $14M | 0.03% |
206,979
+141,979
| +218% | +$10.3M |
|
Similar funds
Adage Capital Partners's Q1 2021 Portfolio in Review
As of Q1 2021, Adage Capital Partners held 1,104 positions worth $49B, up 6.8% from $45.9B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Adage Capital Partners's Q1 2021 filing shows 303 new, 294 increased, 324 reduced and 153 closed positions. Its largest new stake was GW Pharmaceuticals Plc American Depositary Shares: 1,500,000 shares worth $325M. The largest sale was Royalty Pharma, an estimated $665M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.
- Adage Capital Partners's largest Q1 2021 buy was GW Pharmaceuticals Plc American Depositary Shares: 1,500,000 shares worth $325M.
- Adage Capital Partners added most to Alexion Pharmaceuticals in Q1 2021, an estimated $205M increase.
- Adage Capital Partners's biggest Q1 2021 reduction was Royalty Pharma, cutting an estimated $665M.
- Adage Capital Partners fully exited CONCHO RESOURCES INC. in Q1 2021, selling an estimated $175M.
- Adage Capital Partners's ten largest holdings make up 21% of its $49B portfolio in Q1 2021.
- Adage Capital Partners opened 303 new positions and closed 153 in Q1 2021.
- Adage Capital Partners's portfolio value rose 6.8% quarter-over-quarter to $49B.
Based on Adage Capital Partners's 13F filing for Q1 2021, filed 17 May 2021.